Use of a 5-HT3 receptor antagonist for the manufacture of a medicament for the treatment of non-digestive tract derived abdominal disorders associated with pain

Details for Australian Patent Application No. 2005224061 (hide)

Owner Solvay Pharmaceuticals GmbH

Inventors Sann, Holger

Agent Watermark

Pub. Number AU-B-2005224061

PCT Pub. Number WO2005/089732

Priority 04101135.4 19.03.04 EP

Filing date 18 March 2005

Wipo publication date 29 September 2005

Acceptance publication date 27 January 2011

International Classifications

A61K 31/00 (2006.01)

A61K 31/4178 (2006.01)

A61K 31/475 (2006.01) - having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine

Event Publications

5 October 2006 PCT application entered the National Phase

  PCT publication WO2005/089732 Priority application(s): WO2005/089732

27 January 2011 Application Accepted

  Published as AU-B-2005224061

26 May 2011 Standard Patent Sealed

11 October 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005224066-Solid-liquid filtration cloth and filtering device

2005224056-Drug delivery system based on polyethylene vinylacetate copolymers